Skip to main content

Artos Launches Version 2 of Its Life Sciences AI Platform, Turning Teams’ Knowledge into Data

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Version 2 of the Artos platform adds a knowledge layer that keeps a company’s data traceable, connected, and built to last.

Artos, the AI platform that turns the knowledge biotech, pharma, and medtech companies create into data they can build on, today announced Version 2 of the Artos platform. V2 brings its Composer and Sentinel agents together on a new knowledge layer shared by medical writing, regulatory, CMC, safety/PV, labeling, and medical affairs teams across programs.

Composer drafts and updates study reports, investigator’s brochures, narratives, and CMC documents from a team’s own data, keeping them current as that data changes. Sentinel helps teams respond to health authority questions, follow guidance as it changes, and search everything their organization knows, with every answer linked to its source.

Artos has quadrupled its team and doubled the number of organizations it works with in the past six months. More than two dozen, top 100 pharma teams now use the platform, putting more than 100 million pages of regulatory documents, clinical reports, publications, and internal knowledge to work across their programs.

Most AI tools in life sciences are built for a single document or deadline. But the knowledge behind a product keeps growing long after approval: aggregate safety reports, CMC changes, labeling updates across 100+ countries, publications, and medical affairs content. Artos was built for that full lifecycle from the start, so what teams create for regulatory work carries forward into everything that comes next.

The bigger value goes beyond speeding up one document. As Artos expands across functions, each team draws on the same knowledge layer, surfacing insights across programs and reusing content instead of recreating it.

Artos was co-founded by CEO Josh Kim and CTO Varun Patel, who met doing research at the University of Chicago and each bring deep life sciences R&D experience and hands-on AI expertise. “The secret to success in this space is a team where every person deeply understands both the scientific and the technical domains we’re trying to bring value to,” said Kim. The company’s team now includes veterans of Roche, Novartis, SpaceX, and Google.

“Life sciences documentation presents a massive opportunity to create efficiencies. And that starts with seeing the space not as documents that need to be created and managed, but as data that your organization should be able to build on,” said Kim.

About Artos

Artos is the life sciences AI platform that turns the knowledge biotech, pharma, and medtech companies create into data their teams and AI agents can build on. Every statement traces back to its source, related content stays connected, and medical writing, regulatory, CMC, safety/PV, labeling, nonclinical, and medical affairs teams work from one shared knowledge layer. Founded in 2023 and based in San Francisco, Artos is backed by Socii Capital, Horizon VC, and Y Combinator. To learn more, visit artosai.com.

Life sciences documentation presents a massive opportunity to create efficiencies. And that starts with seeing the space not as documents that need to be created and managed, but as data that your organization should be able to build on.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.13
+8.24 (3.20%)
AAPL  353.15
+1.24 (0.35%)
AMD  521.29
+17.88 (3.55%)
BAC  49.02
-0.41 (-0.84%)
GOOG  279.27
+1.67 (0.60%)
META  617.52
-1.35 (-0.22%)
MSFT  504.60
-1.64 (-0.32%)
NVDA  152.91
-2.55 (-1.64%)
ORCL  115.61
+0.61 (0.53%)
TSLA  385.21
+5.10 (1.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.